Product Identifiers
Catalog # | NX28289 |
CAS Number | 1693758-51-8 |
PubChem CID | 91933883 |
Chemical Name | IPI-549 |
IUPAC Name | 2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
InChI | InChI=1S/C30H24N8O2/c1-19(34-29(39)26-27(31)35-37-15-7-14-32-28(26)37)24-16-22-9-6-8-21(13-12-20-17-33-36(2)18-20)25(22)30(40)38(24)23-10-4-3-5-11-23/h3-11,14-19H,1-2H3,(H2,31,35)(H,34,39)/t19-/m0/s1 |
InChIKey | XUMALORDVCFWKV-IBGZPJMESA-N |
SMILES | C[C@H](NC(=O)c1c(N)nn2cccnc12)C3=Cc4cccc(C#Cc5cnn(C)c5)c4C(=O)N3c6ccccc6 |
MDL Number | MFCD30533720 |
Specification
MW | 528.6 |
MF | C30H24N8O2 |
Product Notes | IPI-549 is a selective phosphoinositide-3-kinase (PI3K)-_ inhibitor with IC50 of 16 nM as an immuno-oncology clinical candidate. |
Cat Number | BISN0153 |
Manufacturer | Apollo Scientific |
Country of Origin | United Kingdom |